MSF: AIDS drug shortage threatens Africa


CAPE TOWN, South Africa — Doctors Without Borders warned

on Saturday that a chronic shortage of drugs to treat AIDS

in six African countries could cost thousands of lives and

reverse progress made on the continent most afflicted by the disease.

In recent weeks, some clinics have stopped accepting new patients,

Eric Goemaere, medical coordinator in South Africa of

the organization, which is also known by

its French abbreviation MSF, told The Associated Press.

He said apathy of governments, donors and the organizations

they work with, as well as the global economic crisis, were to blame.

"There's no doubt people will die as a consequence.

It's a catastrophe in the making," Goemaere said

before the opening of

a four-day international AIDS conference in Cape Town.

A newsletter for the conference said,

"Amidst a lingering global recession and reports

that world leaders are retreating on prior commitments,

the 5,000 AIDS researchers, implementers and

community leaders gathering in Cape Town this weekend

are determined to raise their collective voices."

The conference president, Dr. Julio Montaner of the Geneva-based

International AIDS Society, added,

"Either we move forward or we will fall back.

That is the reality we face at this pivotal moment in HIV scale-up."

The countries affected are Zimbabwe, Uganda, Congo, Malawi,

Guinea and South Africa,

with the last suffering the highest rate of AIDS infection in the world.

At the end of 2007, 33 million people worldwide were living

with HIV, according to the World Health Organization.

Two-thirds of them live in sub-Saharan Africa.

The Global Fund to Fight AIDS, Tuberculosis and Malaria,

which provides a quarter of all international financing

to fight AIDS across the world,

has not received $3 billion to $4 billion

in promised funding, according to

Mit Philips of the MSF research center in Brussels.

"Some countries have committed but have

not paid and there's a lot of uncertainty at

an international level whether the Global Fund

will get the money it needs," she said in a telephone interview.

The fund has already slashed 10 percent

from grants already approved last year, Philips said.

The fund's Web site says that, since its creation in 2002,

it has approved $15.6 billion for more

than 572 programs 140 countries.

In addition, Philips said, there has been

no promised increased in funds from

the U.S. President's Emergency Plan for AIDS Relief,

a pet project of President George W. Bush

that is credited with saving millions of lives.

On the campaign trail, President Barack Obama promised

to expand the program by a billion dollars a year.

But Philips said funding has remained flat.

Goemaere said organizations using the project's funds

in Uganda have been told to stop taking on new patients.

For those who do not die, that means getting sicker

and sicker before getting access to the drugs,

that they may need expensive specialist care instead

of that of ordinary health workers, and

a greater likelihood of suffering

side effects from the anti-retrovirals.

"It makes a huge difference if people

come walking in for treatment,

or if they are coming in on stretchers,

" Goemaere said. "We're very scared"

of hearing no new patients must be enrolled.

Local news reports that some AIDS victims

in South Africa's KwaZulu-Natal province

have been forced to halt their drug regimen

raise other issues.

Such patients develop drug-resistance

and then must be treated with

a more expensive cocktail of medication.

Goemaere also feared difficulties in getting drugs

could reverse decades of work to fight the stigma

attached to AIDS: "We will be going back to

the dark times with people thinking that treatment

is not reliable or not accessible, so 'let's hide the disease.'"

The United Nations last month warned governments against

using the global economic crisis as an excuse

to cut funding for fighting AIDS at a time

when there are nearly five new HIV infections

for every two people put on treatment.

"With reports of drug shortages here and elsewhere

foremost on our minds, we must hold

our leaders accountable for the needless deaths

that will result, along with countless preventable infections,

" said the South African co-chairman of the conference,

Dr. Hoosen Jerry Coovadia, who is professor

in HIV/AIDS research at the University of Natal-Durban.


On the Web:

http://www.ias2009.org, official conference site

http://www.msf.org, Doctors Without Borders

             J-L K.
Procurement Consultant
Gsm:    (250) (0) 78-847-0205 (Mtn Rwanda)
Gsm:    (250) (0) 75-079-9819 (Rwandatel)
Home:  (250) (0) 25-510-4140
    P.O. Box 3867
  Kigali - RWANDA
    East AFRICA
Blog: http://cepgl.blogspot.com
Skype ID: kayisa66

No comments:

Post a Comment